Author: Dorron Blumberg

September 1, 2020 – Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $2.5 billion in aggregate principal amount of senior notes due on October 1, 2028, which will bear interest at a rate of 6.125% per annum (the “notes”). Completion of the notes offering is expected to occur on September 16, 2020, and is subject to, among other things, standard closing and market conditions.
 

 

 

September 1 2020 – Holy Cross Health has announced it has begun recruiting and treating patients in a clinical research study to evaluate the safety and effectiveness of LY-CoV555 in patients with early mild to moderate COVID-19. Sponsored by Eli Lilly and Company (Lilly), the BLAZE-1 Study is looking for adults ages 18 or older who have recently tested positive for COVID-19 and are not hospitalized.
 

  

September 1 2020 – If the United States Centers for Disease Control and Prevention (CDC) guidelines aren’t enough to convince you that face shields alone shouldn’t be used to stop the spread of COVID-19, then maybe a new visualization study will. 

 

To increase public awareness about the effectiveness of face shields alone as well as face masks with exhalation valves, researchers from Florida Atlantic University’s College of Engineering and Computer Science used qualitative visualizations to test how face shields and masks with valves perform in impeding the spread of aerosol-sized droplets. Widespread public use of these alternatives to regular masks could potentially have an adverse effect on mitigation efforts.